They could partially replace the current standard method and potentially revolutionize muscle diagnostics. Unclear muscle weakness, paralysis, cramps,…
Last Monday, the U.S. Food and Drug Administration (FDA) approved the Alzheimer's drug aducanumab, using its "accelerated approval" program. Prof. Dr.…